Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study

Sun Min Lim, Byeong Bae Park, Keun Chil Park, Hoon Kyo Kim, Jong Seok Lee, Sung Hwa Bae, Seung Sei Lee, Jin Hyoung Kang, Se Hoon Park, Gyeong Won Lee, Hyo Rac Lee, Jae Hong Seo, Yong Tae Kim, Sung Hyun Yang, Joo Hang Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: To investigate the efficacy, safety, and tolerability of weekly docetaxel treatment in advanced non-small cell lung cancer (NSCLC) patients in Korea. Methods: This prospective observational study included Korean advanced NSCLC patients with Eastern Cooperative Oncology Group performance status

Original languageEnglish
Pages (from-to)207-214
Number of pages8
JournalThoracic Cancer
Volume7
Issue number2
DOIs
Publication statusPublished - 2016 Mar 1

    Fingerprint

Keywords

  • Carcinoma
  • Docetaxel
  • Non-small cell lung cancer
  • Safety

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Lim, S. M., Park, B. B., Park, K. C., Kim, H. K., Lee, J. S., Bae, S. H., Lee, S. S., Kang, J. H., Park, S. H., Lee, G. W., Lee, H. R., Seo, J. H., Kim, Y. T., Yang, S. H., & Kim, J. H. (2016). Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study. Thoracic Cancer, 7(2), 207-214. https://doi.org/10.1111/1759-7714.12315